BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 31031767)

  • 1. Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
    Ali S; Mann-Nüttel R; Schulze A; Richter L; Alferink J; Scheu S
    Front Immunol; 2019; 10():778. PubMed ID: 31031767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.
    Bencze D; Fekete T; Pázmándi K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of type I interferon production by dendritic cells in host defense.
    Fitzgerald-Bocarsly P; Feng D
    Biochimie; 2007; 89(6-7):843-55. PubMed ID: 17544561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings.
    Greene TT; Zuniga EI
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
    Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():2314. PubMed ID: 30344524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.
    Tang F; Du Q; Liu YJ
    Sci China Life Sci; 2010 Feb; 53(2):172-82. PubMed ID: 20596824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted biology of plasmacytoid dendritic cells.
    Swiecki M; Colonna M
    Nat Rev Immunol; 2015 Aug; 15(8):471-85. PubMed ID: 26160613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
    Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
    PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN Sensing by cDCs and CD4
    Shirley JL; Keeler GD; Sherman A; Zolotukhin I; Markusic DM; Hoffman BE; Morel LM; Wallet MA; Terhorst C; Herzog RW
    Mol Ther; 2020 Mar; 28(3):758-770. PubMed ID: 31780366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons in infectious disease.
    McNab F; Mayer-Barber K; Sher A; Wack A; O'Garra A
    Nat Rev Immunol; 2015 Feb; 15(2):87-103. PubMed ID: 25614319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.
    Webster B; Werneke SW; Zafirova B; This S; Coléon S; Décembre E; Paidassi H; Bouvier I; Joubert PE; Duffy D; Walzer T; Albert ML; Dreux M
    Elife; 2018 Jun; 7():. PubMed ID: 29914621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():3070. PubMed ID: 30622542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M.
    Ko YA; Chan YH; Liu CH; Liang JJ; Chuang TH; Hsueh YP; Lin YL; Lin KI
    Front Immunol; 2018; 9():1828. PubMed ID: 30131810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of type I interferons: plasmacytoid dendritic cells and beyond.
    Asselin-Paturel C; Trinchieri G
    J Exp Med; 2005 Aug; 202(4):461-5. PubMed ID: 16103406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.
    García-León ML; Bonifaz LC; Espinosa-Torres B; Hernández-Pérez B; Cardiel-Marmolejo L; Santos-Preciado JI; Wong-Chew RM
    Hum Vaccin Immunother; 2015; 11(7):1762-9. PubMed ID: 26075901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmacytoid dendritic cells: the novel Eldorado for antiviral therapy?].
    Smith N; Herbeuval JP
    Biol Aujourdhui; 2015; 209(2):135-44. PubMed ID: 26514383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.